Ibio Inc (IBIO) SEC 13F Holdings (Q2 2026) — Net Institutional Activity: $32.8M

IBIO ranks #5873 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

56 institutions disclose a position in IBIO, but none treat it as a major bet — even Silverarc Capital Management, LLC, its most concentrated holder, allocates just 0.6% of its own portfolio to it.

Silverarc Capital Management, LLC has added to its IBIO position for two straight quarters, increasing it by $6.0M to reach $6.2M today.

Frazier Life Sciences Management, L.P. has trimmed its IBIO position for two straight quarters, cutting it by $351.6K while still holding $3.4M.

IBIO is up 0.8% today, and institutions have been net buyers of $32.8M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

IBIO reported a net loss of $33.0M over the trailing twelve months.

• Not yet profitable — net loss of $33.0M over the trailing twelve months
• Revenue declined 75.0% year over year
• Net income declined year over year, from -$18.4M to -$33.0M
• Operating cash flow was negative, using $23.2M in cash
• Current ratio of 7.85x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.16x equity — within a conventional range